BackBafna Pharmaceuticals Limited Overview

Bafna Pharmaceuticals Limited Receivables

Bafna Pharmaceuticals Limited's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Bafna Pharmaceuticals Limited Receivables History

Loading

Bafna Pharmaceuticals Limited vs. peers: Receivables Comparison

Loading

Bafna Pharmaceuticals Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bafna Pharmaceuticals Limited (BAFNAPH.NS) FAQ

The latest receivables for BAFNAPH.NS is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Bafna Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BAFNAPH.NS's receivables moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bafna Pharmaceuticals Limited's operating scale or balance-sheet position.

A receivables figure of $0 for BAFNAPH.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BAFNAPH.NS's receivables ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.